This study will check muscle mass, physical function, and cancer-related aging in children and young adults (8-21 years old) undergoing cancer treatment. In this study, we want to learn how muscle and physical function (strength, mobility, endurance) change in children and young adults who undergoing cancer treatment and how to measure these changes.
The purpose of this study is to determine the extent to which various forms of language exposure affect a second-language Spanish speaker's production of a specific dialectal feature
Do you have asymptomatic multiple myeloma, also known as smoldering multiple myeloma? You may be able to take part in a research study to help us learn more about the effectiveness of a drug called daratumumab in combination with lenalidomide and steroids.
Have you been diagnosed with oropharyngeal (tonsil or tongue base) cancer. If so, you may be able to take part in a research study testing markers to determine who may be appropriate for less aggressive therapy and markers to determine if recurrent tumors can be detected earlier.
Have you been diagnosed with CD30 negative peripheral T-cell lymphoma? If so, you may be able to take part in a research study that will look at the safety of adding the new study drug duvelisib, or the new study drug CC-486, to the standard chemotherapy treatment for your disease. Please contact us with questions about eligibility, or if you wish to know more.
Do you have relapsed or refractory multiple myeloma? Have you received at least one type of treatment? If so, you may be able to take part in a research study looking at the the safety of giving an investigational medication to patients with multiple myeloma.
Do you currently have a cancerous tumor that has advanced or progressed? Are you currently not on any standard of care treatment options? If so, you may be able to take part in a research study to see if a new drug may be able to slow the growth of your cancer. Travel reimbursement and compensation provided.
This study is for people who have chronic tendonitis of the shoulder, glute or elbow and would like to seek treatment via the TenJet device by Dr. David Berkoff at UNC Orthopedics. TenJet is a needle-like device specifically designed to treat tendinosis or chronic tendinitis and provide relief from chronic tendon pain. The device uses a pressurized, high-velocity jet of saline to remove diseased tendon tissue while keeping healthy tissue.
In this study, we will learn more about the safety and effectiveness of a study treatment that is injected into one of the kidneys of patients with Chronic Kidney Disease and Type 2 Diabetes.
The goal of this study is to learn more about what happens when cancer drugs that target specific changes in a tumor's DNA are used to treat tumors that have those DNA changes. We call the use of these types of drugs targeted therapy. A targeted therapy delivers a treatment that is aimed at a specific molecular feature of the cancer cell. The cancer cell being targeted contains a change in the DNA that results in the production of abnormal proteins. These proteins let the cancer cells grow uncontrollably or prevent the body from eliminating the cancer cells. The targeted therapy prevents the abnormal proteins from stimulating the growth of the cancer.